• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Jean Waters, UK

    Jean Waters, UK

  • Zabun Nassar, England

    Zabun Nassar, England

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Purningam Jacob, India

    Purningam Jacob, India

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • John Russo, USA

    John Russo, USA
    final3878

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Mike Cels, Canada

    Mike Cels, Canada

  • Willi Klein, UK

    Willi Klein, UK

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Olga, Argentina

    Olga, Argentina

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Ali Var, Turkey

    Ali Var, Turkey

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Ann Nicol, USA

    Ann Nicol, USA

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Anna Barrow, UK

    Anna Barrow, UK

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login